Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate whether there are genetic differences between patients with rheumatic heart disease and members of the general population.

Clinical Trial Description

The investigators will micro-array genotype approximately 300,000 single nucleotide polymorphisms (SNP) using DNA samples from patients with rheumatic heart disease (cases) from New Caledonia and Fiji, and members of the general population (controls) from New Caledonia, Vanuatu and Fiji. The investigators will perform standard quality control checks on the SNP data using measures such as call rate, heterozygosity, duplication and relatedness, and exclude variants on the basis of deviation from Hardy-Weinberg equilibrium and minor allele frequency. We will also impute variants not present on the micro-array with reference to the latest release of 1000 Genomes data and whole-genome sequence data from sixty Melanesian individuals from New Caledonia from the phenotypic extremes in this study.

The investigators will conduct a discovery analysis in using a genome-wide association study approach focusing on Oceanic cases and controls from the Francophone nations of New Caledonia and Vanuatu. This analysis will be corrected for bias due to population stratification using the Linear Mixed Model (LMM) and consider additive, dominant and recessive genetic models. The investigators will then perform LMM association testing for variants with P-value in the discovery analysis less than 1x10^-5 in Oceanic cases and controls from Fiji and combine the association statistics by fixed-effects meta-analysis. The investigators will consider variants with significant effects in the same direction in discovery and replication analyses with combined P-value less than 1x10^-8 to have replicated. Unless there is clear evidence that associated variants are specific to Oceanic populations, further replication analyses for associated variants in cases and controls of Indian Descent from Fiji, as well as individuals of other and admixed ethnicities from both Fiji and New Caledonia.

Recruitment completed in December 2013. After receipt of funding from the British Heart Foundation, genotyping and analysis will begin in July 2014. ;

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02188862
Study type	Observational
Source	University of Oxford
Contact
Status	Completed
Phase	N/A
Start date	September 2012
Completion date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05991219` - Screening and Secondary Prevention Rheumatic Heart Disease Study
Completed	`NCT02661763` - Rheumatic Heart Disease Study in Lusaka	N/A
Completed	`NCT01178710` - Effect of Simvastatin on Cardiac Function	N/A
Recruiting	`NCT05693545` - GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial	Phase 2
Completed	`NCT06150274` - Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy	N/A
Terminated	`NCT03926156` - RIvoraxaban in Mitral Stenosis	Phase 3
Recruiting	`NCT05783375` - Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda	N/A
Completed	`NCT02474108` - Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement	N/A
Recruiting	`NCT04556188` - The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa
Recruiting	`NCT03991910` - The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients	Phase 3
Active, not recruiting	`NCT03346525` - Determining the Impact of Penicillin in Latent RHD: The GOAL Trial	Phase 2
Recruiting	`NCT05504928` - Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease	N/A
Not yet recruiting	`NCT03549052` - Right Ventricular Echo Assessment in Mitral Valve Replacement
Recruiting	`NCT05487469` - Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass	N/A
Completed	`NCT05276999` - Rheumatic Heart Disease Community Streptococcal Treatment Program "RESET"	N/A
Completed	`NCT05668611` - Train the Trainer Curriculum to Scale up AI Supported Echo for RHD Screening in a Public Health System	N/A
Active, not recruiting	`NCT05211024` - A Long-term Follow up Study for Patients Who Participated in the GOAL Trial (GOAL-Post)
Withdrawn	`NCT02832531` - INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority	Phase 3
Completed	`NCT01794884` - Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery	Phase 2
Completed	`NCT00264524` - DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease	N/A